{"id":224537,"date":"2026-08-31T15:39:30","date_gmt":"2026-08-31T10:09:30","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=224537"},"modified":"2026-08-31T15:39:30","modified_gmt":"2026-08-31T10:09:30","slug":"why-neuland-laboratories-share-price-price-fall-2026-08-31","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-08-31\/","title":{"rendered":"Neuland Laboratories (NEULANDLAB) Share Price Falls 3.55%: What the Stock News Shows Today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/neulandlab\/neuland-laboratories-ltd-share-price-today\">Neuland Laboratories (NEULANDLAB)<\/a> share price fell to Rs 22,400 today, down 3.55% from the previous close. Market cap was Rs 29,797.99 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong>&nbsp;&nbsp;&nbsp;31 August 2026 at 3:33:21 PM IST<\/p>\n<p style=\"margin-top:0!important;\">Neuland Laboratories Share Price fell today to Rs 22,400, down 3.55% from the previous close, with the company\u2019s market capitalisation at Rs 29,797.99 crore. The move places Neuland Laboratories in focus for investors following Neuland Laboratories Share Price Today and the latest Neuland Laboratories Stock News, even though the supplied data confirms the price event without establishing a company-specific catalyst. Neuland Laboratories Share Price has moved sharply enough to draw attention because the decline came after a session that opened and reached Rs 23,225 before easing to the day\u2019s low of Rs 22,400. On Univest, the same data points help frame today\u2019s share price fall against the stock\u2019s valuation, healthcare sector position and peer comparison.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-08-31\/#Neuland_Laboratories_NEULANDLAB_Share_Price_Today_Price_Action_Analysis\" title=\"Neuland Laboratories (NEULANDLAB) Share Price Today: Price Action Analysis\">Neuland Laboratories (NEULANDLAB) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-08-31\/#Neuland_Laboratories_NEULANDLAB_Fundamental_Analysis\" title=\"Neuland Laboratories (NEULANDLAB) Fundamental Analysis\">Neuland Laboratories (NEULANDLAB) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-08-31\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-08-31\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-08-31\/#Why_Investors_Are_Watching_Neuland_Laboratories\" title=\"Why Investors Are Watching Neuland Laboratories\">Why Investors Are Watching Neuland Laboratories<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-08-31\/#About_Neuland_Laboratories\" title=\"About Neuland Laboratories\">About Neuland Laboratories<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-08-31\/#Track_Neuland_Laboratories_Share_Price_on_Univest\" title=\"Track Neuland Laboratories Share Price on Univest\">Track Neuland Laboratories Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-08-31\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-08-31\/#Why_is_Neuland_Laboratories_Share_Price_falling_today\" title=\"Why is Neuland Laboratories Share Price falling today?\">Why is Neuland Laboratories Share Price falling today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-08-31\/#What_is_Neuland_Laboratories_Share_Price_Today\" title=\"What is Neuland Laboratories Share Price Today?\">What is Neuland Laboratories Share Price Today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-08-31\/#What_is_Neuland_Laboratories_market_capitalisation\" title=\"What is Neuland Laboratories market capitalisation?\">What is Neuland Laboratories market capitalisation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-08-31\/#What_do_Neuland_Laboratories_valuation_ratios_show\" title=\"What do Neuland Laboratories valuation ratios show?\">What do Neuland Laboratories valuation ratios show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-08-31\/#How_strong_are_Neuland_Laboratories_profitability_ratios\" title=\"How strong are Neuland Laboratories profitability ratios?\">How strong are Neuland Laboratories profitability ratios?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-08-31\/#How_does_Neuland_Laboratories_compare_with_pharma_peers\" title=\"How does Neuland Laboratories compare with pharma peers?\">How does Neuland Laboratories compare with pharma peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-08-31\/#What_is_the_dividend_yield_of_Neuland_Laboratories\" title=\"What is the dividend yield of Neuland Laboratories?\">What is the dividend yield of Neuland Laboratories?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Neuland_Laboratories_NEULANDLAB_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Neuland Laboratories (NEULANDLAB) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 22,400<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 23,225.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 825.45 (-3.55%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 23,225<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 23,225<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 22,400<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5.21 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 29,797.99 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Neuland Laboratories Share Price Today closed the session at Rs 22,400, compared with the previous close of Rs 23,225.45. That leaves a day change of Rs -825.45, or -3.55%. The stock opened at Rs 23,225 and also hit the same level as the day high, before touching the day low of Rs 22,400. This means the session moved steadily lower after the open, and the final price matched the day\u2019s low.<\/p>\n<p>For context, Neuland Laboratories Share Price News also needs to be read with the company\u2019s size. Neuland Laboratories is categorised as a Large Cap stock, and its market capitalisation stands at Rs 29,797.99 crore. The turnover for the day is Rs 5.21 crore. The supplied data confirms the price event, but it does not establish a company-specific reason behind the decline.<\/p>\n<p>From a market-news perspective, Neuland Laboratories Share Price Fall is best described as a same-day decline that followed a flat opening near the prior close and ended at the session low. Investors tracking Neuland Laboratories Stock Falling Today will therefore focus on whether the next session keeps the price near this level or recovers back toward the previous close. Neuland Laboratories Share Price Update, in other words, is about the direction of the current session rather than any uncovered trigger.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Neuland_Laboratories_NEULANDLAB_Fundamental_Analysis\"><\/span><strong>Neuland Laboratories (NEULANDLAB) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 29,797.99 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">59.86x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14.74x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.43%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 387.98<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,575.41<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.15%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Neuland Laboratories Fundamental Analysis shows a premium valuation profile in the context of the broader healthcare universe. The stock trades at a P\/E ratio of 59.86 and a P\/B ratio of 14.74. Its ROE is 21.43%, while ROCE stands at 27.5%, both of which indicate strong return metrics on the supplied figures. EPS is Rs 387.98 and book value per share is Rs 1,575.41, which gives a clear accounting and earnings base for Neuland Laboratories Share Price Today.<\/p>\n<p>Dividend yield is 0.15%, which is a factual income metric and not a forecast. On market capitalisation, Neuland Laboratories Market Cap of Rs 29,797.99 crore places it far above the median market cap of Rs 670.73 crore in the supplied industry benchmark. Enterprise value is not supplied, so the analysis stays with the exact available data. Neuland Laboratories Stock Analysis therefore reflects a company with strong profitability ratios and a valuation that is higher than many industry names in the benchmark set. For readers following Neuland Laboratories Latest News, the key point is that today\u2019s share price fall occurred against a background of substantial earnings and return metrics, not against weak fundamental disclosure in the supplied dataset.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">59.86x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.21x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.1x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.7x to 672.45x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14.74x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.88x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.19x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.43%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.68%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.6%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.27%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 29,797.99 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 670.73 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,040.53 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The sector snapshot places Neuland Laboratories in Healthcare, within Pharmaceuticals &amp; Drugs, against a same-industry benchmark of 203 companies. That is an important reference point for Neuland Laboratories Share Price because valuation and return ratios can be read against a broad peer universe. The company\u2019s P\/E of 59.86 is above the benchmark median of 31.21 and above the benchmark average of 48.1. Its P\/B of 14.74 is also above the benchmark median of 2.88 and above the benchmark average of 4.19.<\/p>\n<p>On profitability, Neuland Laboratories shows ROE of 21.43% versus the benchmark median of 11.78% and average of 10.68%. ROCE of 27.5% is also above the benchmark median of 13.6% and average of 13.27%. In market-cap terms, the company\u2019s Rs 29,797.99 crore value is far above the benchmark median of Rs 670.73 crore and above the benchmark average of Rs 14,040.53 crore. This means Neuland Laboratories Share Price is being viewed in a large-company context inside a wide pharmaceuticals peer set, where the company stands well above the benchmark midpoint on size and returns.<\/p>\n<p>For investors searching Neuland Laboratories Stock News or Neuland Laboratories News Today, the sector takeaway is simple: the healthcare and pharmaceuticals backdrop is information-rich, and the company\u2019s valuation sits above the benchmark middle while profitability ratios also sit above the benchmark middle. The supplied data supports comparison, not a conclusion about cause.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,60,696.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38.09<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,46,062.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">84.12<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,91,515.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">87.81<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.34<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,18,403.7<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.24<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.39<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,14,554.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.99<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Against peers, Neuland Laboratories Share Price sits in a group that includes Sun Pharmaceutical Industries, Divi\u2019s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla The company\u2019s market capitalisation of Rs 29,797.99 crore is below Sun Pharma, Divi\u2019s, Torrent, Zydus and Cipla in the supplied peer set, but it is still well above the benchmark median for the industry.<\/p>\n<p>On valuation, Neuland Laboratories\u2019 P\/E of 59.86 is higher than Sun Pharma, Zydus and Cipla, but lower than Divi\u2019s, Torrent and Laurus Labs in the wider peer data. Its P\/B of 14.74 is also above Sun Pharma, Zydus and Cipla, while remaining below Torrent and Laurus Labs. ROE at 21.43% is stronger than Sun Pharma, Divi\u2019s, Zydus and Cipla, though below Torrent and Lupin in the broader peer field. ROCE of 27.5% is above Sun Pharma, Divi\u2019s, Zydus and Cipla, and close to the stronger return profiles in the group. For readers tracking Neuland Laboratories Share Price Today, these comparisons show a stock with richer valuation ratios but also stronger return metrics than several of the listed healthcare peers.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Neuland_Laboratories\"><\/span><strong>Why Investors Are Watching Neuland Laboratories<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Neuland Laboratories Share Price fell 3.55% today to Rs 22,400 from the previous close of Rs 23,225.45.<\/li>\n<li>The day open, day high and session start were all Rs 23,225, while the day low and last price were Rs 22,400.<\/li>\n<li>Market capitalisation stands at Rs 29,797.99 crore, and the company is classified as a Large Cap stock.<\/li>\n<li>P\/E is 59.86, P\/B is 14.74, ROE is 21.43% and ROCE is 27.5% in the supplied fundamentals.<\/li>\n<li>The healthcare industry benchmark covers 203 companies, and Neuland Laboratories\u2019 valuation and returns sit above the benchmark median on several measures.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Neuland_Laboratories\"><\/span><strong>About Neuland Laboratories<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Neuland Laboratories operates in Healthcare and the Pharmaceuticals &amp; Drugs industry. The supplied data identifies the company through its sector and industry classification, and the current analysis therefore stays focused on those verified identifiers. Neuland Laboratories Share Price Today is being tracked in the market in the context of this sector positioning and the company\u2019s exact financial ratios.<\/p>\n<p>For anyone following Neuland Laboratories Stock Analysis, the useful starting point is the combination of market cap, profitability and valuation metrics already supplied. Univest uses these verified data points to keep the discussion factual and aligned with the company\u2019s listed identity.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Neuland_Laboratories_Share_Price_on_Univest\"><\/span><strong>Track Neuland Laboratories Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use&nbsp;<a href=\"https:\/\/univest.in\/stocks\/neulandlab\/neuland-laboratories-ltd-share-price-today\">Neuland Laboratories (NEULANDLAB) live share-price page<\/a>,<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top decliners and related market analysis.<\/p>\n<p>You can track Neuland Laboratories Share Price Live on Univest with the latest market cap, P\/E ratio, P\/B ratio, ROE, ROCE, EPS, book value, dividend yield, sector context and peer comparison. Univest also helps users follow Neuland Laboratories Share Price Update and Neuland Laboratories Share News in one place.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong>&nbsp;&nbsp;Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Neuland_Laboratories_Share_Price_falling_today\"><\/span><strong>Why is Neuland Laboratories Share Price falling today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Neuland Laboratories Share Price fell 3.55% to Rs 22,400 today. The supplied data confirms the move and the session range, but it does not establish a company-specific catalyst for the decline.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Neuland_Laboratories_Share_Price_Today\"><\/span><strong>What is Neuland Laboratories Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Neuland Laboratories Share Price Today is Rs 22,400. It is down from the previous close of Rs 23,225.45, after opening and touching Rs 23,225 before ending at the day\u2019s low.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Neuland_Laboratories_market_capitalisation\"><\/span><strong>What is Neuland Laboratories market capitalisation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Neuland Laboratories market capitalisation is Rs 29,797.99 crore. The stock is classified as a Large Cap company in the supplied data, which helps frame its position in the healthcare universe.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_Neuland_Laboratories_valuation_ratios_show\"><\/span><strong>What do Neuland Laboratories valuation ratios show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Neuland Laboratories trades at a P\/E of 59.86 and a P\/B of 14.74. In the supplied industry benchmark, both ratios sit above the benchmark median, which provides valuation context. The company trades at a P\/E ratio of 59.86x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_strong_are_Neuland_Laboratories_profitability_ratios\"><\/span><strong>How strong are Neuland Laboratories profitability ratios?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Neuland Laboratories reports ROE of 21.43% and ROCE of 27.5%. Both figures are above the supplied industry benchmark median, while EPS is Rs 387.98 and book value is Rs 1,575.41.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Neuland_Laboratories_compare_with_pharma_peers\"><\/span><strong>How does Neuland Laboratories compare with pharma peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Neuland Laboratories has a smaller market cap than Sun Pharma, Divi\u2019s, Torrent, Zydus and Cipla in the supplied peer set, but its ROE and ROCE are stronger than several of those peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_dividend_yield_of_Neuland_Laboratories\"><\/span><strong>What is the dividend yield of Neuland Laboratories?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Neuland Laboratories has a dividend yield of 0.15%. This is a factual income metric in the current dataset and should be read alongside the company\u2019s earnings, book value and valuation ratios.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Neuland Laboratories Share Price falls to Rs 22,400. marking a 3.55% fall today. Market cap stands at Rs 29,797.99 crore.<\/p>\n","protected":false},"author":29,"featured_media":224535,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-224537","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["224535"],"rank_math_title":["Neuland Laboratories Share Price Fall: Rs 22,400 Update"],"rank_math_description":["Neuland Laboratories Share Price fell 3.55% to Rs 22,400. Read today\u2019s price action, valuation metrics, sector comparison and stock news context."],"rank_math_focus_keyword":["Neuland Laboratories Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Neuland_Laboratories_NEULANDLAB_Share_Price_Falls_355_What_the_Stock_News_Shows_Today_bearish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/224537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=224537"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/224537\/revisions"}],"predecessor-version":[{"id":224538,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/224537\/revisions\/224538"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/224535"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=224537"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=224537"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=224537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}